Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M, Iwamoto T, Matsuoka J, Nogami T, Motoki T, Shien T, Taira N, Niikura N, Hayashi N, Ohtani S, Higaki K, Fujiwara T, Doihara H, Symmans WF, Pusztai L. Itoh M, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z. Epub 2013 Dec 15. Breast Cancer Res Treat. 2014. PMID: 24337596 Free article.
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
Iwamoto T, Kumamaru H, Miyata H, Tomotaki A, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Matsuoka J, Doihara H, Kinoshita T, Nakamura S, Tokuda Y. Iwamoto T, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2016 Apr;156(3):485-494. doi: 10.1007/s10549-016-3770-7. Epub 2016 Apr 5. Breast Cancer Res Treat. 2016. PMID: 27048417 Free PMC article.
N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
Hara A, Taira N, Mizoo T, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Miyoshi S. Hara A, et al. Among authors: matsuoka j. Breast Cancer. 2017 Mar;24(2):254-262. doi: 10.1007/s12282-016-0696-1. Epub 2016 Apr 11. Breast Cancer. 2017. PMID: 27068825 Free article.
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
Takahashi Y, Iwamoto T, Suzuki Y, Kajiwara Y, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, Matsuoka J, Doihara H, Toyooka S. Takahashi Y, et al. Among authors: matsuoka j. Clin Breast Cancer. 2020 Apr;20(2):117-124.e4. doi: 10.1016/j.clbc.2019.07.001. Epub 2019 Sep 9. Clin Breast Cancer. 2020. PMID: 31570267 Free article.
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.
Iwamoto T, Lee JS, Bianchini G, Hubbard RE, Young E, Matsuoka J, Kim SB, Symmans WF, Hortobagyi GN, Pusztai L. Iwamoto T, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2011 Nov;130(1):155-64. doi: 10.1007/s10549-011-1706-9. Epub 2011 Aug 11. Breast Cancer Res Treat. 2011. PMID: 21833625
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.
Shimoyama K, Kagawa S, Ishida M, Watanabe S, Noma K, Takehara K, Tazawa H, Hashimoto Y, Tanabe S, Matsuoka J, Kobayashi H, Fujiwara T. Shimoyama K, et al. Among authors: matsuoka j. Breast Cancer Res Treat. 2015 Feb;149(3):597-605. doi: 10.1007/s10549-015-3265-y. Epub 2015 Jan 24. Breast Cancer Res Treat. 2015. PMID: 25616354
249 results